Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Burkitt Lymphoma × Carmustine × Clear all

Phase

Phase 2 15 Phase 1 4 Phase NA 1 Phase 4 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 1 Burkitt Lymphoma 1

Interventions

Cyclophosphamide 2 Vincristine 1 Thiotepa 1 Tenofovir 1 Radiotherapy 1 Methotrexate 1 Melphalan 1 Lomustine 1 Ifosfamide 1 Idarubicin 1 Filgrastim 1 Etoposide 1 Doxorubicin 1 Dexamethasone 1 Cytarabine 1 Carmustine 1 Antilymphocyte Serum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05518383 2022-08-26

B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

Federal Research Institute of Pediatric Hematology, Oncology and Immunology

Phase 4 Recruiting

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡